KLG Stock +78.58% In 3 Months Since We Picked KLG Stock +78.58% In 3 Months Since We Picked Unlock All Top Buy Picks

Range Low Price High Price Comment
30 days $4.61 $7.24 Friday, 26th Apr 2024 AFMD stock ended at $5.03. This is 3.07% more than the trading day before Thursday, 25th Apr 2024. During the day the stock fluctuated 6.35% from a day low at $4.88 to a day high of $5.19.
90 days $4.25 $7.24
52 weeks $2.24 $11.10

Historical Affimed N.V. prices

Date Open High Low Close Volume
Jul 13, 2022 $28.80 $30.90 $28.40 $30.60 56 766
Jul 12, 2022 $29.00 $29.90 $27.70 $29.70 95 732
Jul 11, 2022 $31.10 $31.10 $28.70 $28.80 57 779
Jul 08, 2022 $31.70 $32.30 $30.20 $31.10 99 416
Jul 07, 2022 $30.70 $33.20 $30.10 $32.20 189 291
Jul 06, 2022 $29.90 $31.00 $29.90 $30.40 59 919
Jul 05, 2022 $27.60 $30.30 $27.50 $30.00 122 987
Jul 01, 2022 $27.90 $28.60 $27.30 $28.10 42 130
Jun 30, 2022 $27.50 $27.95 $26.95 $27.70 65 395
Jun 29, 2022 $27.80 $28.20 $26.95 $28.10 60 077
Jun 28, 2022 $29.60 $29.60 $27.50 $27.80 120 824
Jun 27, 2022 $27.10 $29.75 $27.10 $29.20 125 391
Jun 24, 2022 $27.70 $28.65 $27.10 $27.10 544 759
Jun 23, 2022 $27.60 $28.50 $27.00 $28.40 109 913
Jun 22, 2022 $25.00 $28.00 $24.60 $27.30 109 801
Jun 21, 2022 $25.50 $26.55 $25.40 $25.60 102 760
Jun 17, 2022 $23.40 $25.95 $23.40 $24.80 123 215
Jun 16, 2022 $23.20 $23.50 $22.30 $23.20 72 834
Jun 15, 2022 $23.20 $24.50 $22.60 $23.70 148 396
Jun 14, 2022 $23.70 $24.09 $22.50 $22.70 79 063
Jun 13, 2022 $24.70 $25.00 $23.40 $23.70 98 188
Jun 10, 2022 $26.80 $26.80 $25.50 $26.00 124 137
Jun 09, 2022 $28.90 $30.00 $27.30 $27.40 64 811
Jun 08, 2022 $29.40 $30.65 $28.80 $29.20 114 246
Jun 07, 2022 $27.70 $29.80 $27.70 $29.60 98 309
Click to get the best stock tips daily for free!

About Affimed N.V.

Affimed N.V. Affimed N.V., a clinical-stage biopharmaceutical company, focuses on discovering and developing cancer immunotherapies in the United States, Germany, and rest of Europe. Its lead product candidate is AFM13, which has completed Phase II clinical study for peripheral T-cell lymphoma; in Phase IIa clinical trial for CD30-positive lymphoma; and in Phase I clinical trial for hodgkin lymphoma. The company is also developing AFM24, a tetravalent, bispec... AFMD Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT